SFX by Ex Libris Inc.

Title:	Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling
Source:	Science [0036-8075] Min, J H yr:2002

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Stebbins, C E E. "Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function." Science 284.5413 (1999): 455-461.
description	2.	Semenza, G. "Targeting HIF-1 for cancer therapy." Nature reviews. Cancer 3.10 (2003): 721-732.
description	3.	Zheng, N. "Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex." Nature 416.6882 (2002): 703-9.
description	4.	Hon, W. "Structural basis for the recognition of hydroxyproline in alpha IF-1 alpha by pVHL." Nature 417.6892 (2002): 975-978.
description	5.	French, Samuel W A. "A modeled hydrophobic domain on the TCL1 oncoprotein mediates association with AKT at the cytoplasmic membrane." Biochemistry (2002): 6376-82.
description	6.	Harris, A. "Hypoxia - A key regulatory factor in tumour growth." Nature reviews. Cancer 2.1 (2002): 38-47.
description	7.	Pavletich, M. "Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex." Nature 408.6810 (2000): 381-386.
description	8.	Semenza, G L. "Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics." Oncogene 29.5 (2009): 625-634.
description	9.	Elledge, S J J. "SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box." Cell 86.2 (1996): 263-74.
description	10.	Maxwell, P. "The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis." Nature 399.6733 (1999): 271-275.
description	11.	Jaakkola, P. "Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation." Science 292.5516 (2001): 468-72.
description	12.	Chen, G E. "Construction, expression, purification and functional analysis of recombinant NF kappa B p50/p65 heterodimer." Protein engineering 12.5 (1999): 423-428.
description	13.	Jarmuz, A.. "An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22." Genomics 79.3 (2002): 285-296.
description	14.	Niklason, L E E. "Functional arteries grown in vitro." Science 284.5413 (1999): 489-93.
description	15.	Kaelin, T. "Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase." Science 284.5414 (1999): 657-61.
description	16.	Petroski, Matthew D. "Evaluation of a Diffusion-Driven Mechanism for Substrate Ubiquitination by the SCF-Cdc34 Ubiquitin Ligase Complex." Molecular cell 24.4 (2006): 523-34.
description	17.	Shiroishi, M. "Structural Consequences of Mutations in Interfacial Tyr Residues of a Protein Antigen-Antibody Complex: THE CASE OF HyHEL-10-HEL." The Journal of biological chemistry 282.9 (2007): 6783-6791.
description	18.	Melillo, G. "Inhibiting hypoxia-inducible factor 1 for cancer therapy." Molecular cancer research 4.9 (2006): 601-605.
description	19.	Kerbel, R. "Clinical translation of angiogenesis inhibitors." Nature reviews. Cancer 2.10 (2002): 727-739.
description	20.	Cheng, J. "Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery." Biomaterials 28.5 (2006): 869-876.